Advice Pool - Finance

This column has previously discussed “picturing the future that we desire”, and outlining a plan to achieve it. We mentioned that the plan must include goal-setting, measurement, and implementation. That implementation is this column’s focus.

Putting the plan i

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

nto action is what implementation is all about. Its one thing to have goals, but without concrete steps to achieve them, they remain dreams. The last column discussed measuring the money required for each of these goals. Now it’s time to figure out how we’re goi

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

g to put that money together.

Of course, the first step is the obvious one. We must have a source of income. This could be a salary, an endowment, or even a loan (although we’d normally advise against that last option). One might consider multiple sources of in

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

come. This protects against undue dependence on one source.

Assuming that some income exists, we can begin to make plans for saving. Based upon our analysis, we can determine how much must be saved on a daily, weekly, monthly, or annual basis to reach our goals

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

We can then consider if it is possible to grow the money fast enough to reach our target date.

If, in the end, we find ourselves unable to save adequately for our goals, we must consider that the problem may not be in our plan, but in our income levels. Someti

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

mes it’s simply a matter of recognizing that goals may be unattainable without adjusting income levels. This might involve second jobs, or side businesses, or rather may require stepping back from the current situation entirely, and increasing employability thro

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

gh education or training. Furthermore, it might suggest that new, creative ideas should be considered. Alternatively, it might simply involve selling off unproductive assets. Whatever the case may be, the income level is a crucial part of any financial strategy,

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

and one often overlooked by investment professionals.

Finally, once the income levels and saving decisions have been established, we turn to the final component: the investment strategy. The final strategy may include many different types of investments, and u

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

e many different types of methods, but in the end, it should always be focused on the goals.

For example, if the goal is to purchase a house in 1 year, investing in stocks may not be the optimal strategy unless you intend to take a great deal of risk. On the ot

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

her hand, if you plan to purchase a house when you have earned enough money, but plan to remain flexible regarding the specific time, stocks may be more viable.

This brings us to the consideration of asset types. This is one of the most critical decisions to ma

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e. There are at least a dozen different types of assets to choose from. Some of the most popular are:

Stocks Mutual Funds Real Estate Limited Partnerships

Art & Collectibles Gold/Commodities Bonds Insurance

Businesses Derivatives

Of course, this list could g

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

o on, but we’ll focus on some of these. First, let’s dispose of the easy ones. Investing in a Business can be a great choice for someone with a solid business plan and sufficient time and capital to make it work. However, many businesses require a full-time comm

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

tment, and unless one is able to give up their regular income, it can be a problem. It is possible to start a business part-time, depending on the type, and this may be an option for some. Additionally, one could invest in someone else’s business, but here one m

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ust be concerned with issues of honesty, compatibility, and incentive. Finally, investing in a business carries with it liquidity problems, because one cannot always sell a business for what its worth without first locating an ideal buyer. Thus, if you’ve planne

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

to sell at a certain date, in anticipation of reaching a goal, you may have trouble.

Limited Partnerships carry with them unnecessary problems, largely because there is not a great market for these either. Thus, even when they have value, one may not be able t

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

o sell them easily. In this way they resemble investing in small businesses, and carry the same risks.

Insurance truly should not be considered an investment, but I include it here because it is so often sold as an investment. In many ways, it can help one plan

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

for tax considerations, but as a pure investment, it is a non-starter.

Art & Collectibles can sometimes increase in value over time, and for those with specialized knowledge in a certain area, it may be a wise speculation. However, much like running a business,

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

it takes time and energy, and has liquidity problems. Still, these can be a small proportion of a portfolio for some investors.

Commodities are bulk holdings of any uniform item for which all have a uniform value. This would include oil, orange juice, coal, si

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ver, or pork bellies. Gold is a commodity with unique qualities because of its long history of use as money and reputation as a dependable store of value. All commodities have fluctuating prices in common, and those who invest in commodities generally have an in

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

timate knowledge of the market for that specific good. Over 90% of people who invest in commodities lose money, while the experts generally make a comfortable living. Investing in commodities can be extremely risky for those who do not have specialized knowledge

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/104511/advicepool-Creating-a-Financial-Future--Putting-Your-Plan-Into-Action-Part-1.html">Creating a Financial Future - Putting Your Plan Into Action Part 1</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/104511/advicepool-Creating-a-Financial-Future--Putting-Your-Plan-Into-Action-Part-1.html]Creating a Financial Future - Putting Your Plan Into Action Part 1[/url]

Machining refers to the industrial process of cutting and fabricating metals and other materials into predetermined shapes and sizes. Machining process is controlled with the help of computer numeric control (CNC) software that guides the cutting equipment along the lines and arcs of a computer aided design (CAD) drawing.

Some of the most talented people in our society are in trouble with the law, some serving time in federal and state prisons. Some are waiting to be sentenced for crimes of which they have been convicted in courts of law. From my experience, those who succeed temporally in life started from a spiritual base. They were raised in good homes and benefited from neighborhood, church, and school leaders. Many were Little Leaguers and good Boy Scouts. Now they are in trouble and their families are disgraced and humiliated. What went wrong?

One way of jumpstarting you link campaign is to get directory links. Building links, by listing your website in the search engines and directories, is one way of increasing your link popularity, especially if yours is a new site or one with no inbound links.

Tags

Links

Advice Pool - Creating a Financial Future - Putting Your Plan Into Action Part 1

Related Articles: